A detailed history of Jaffetilchin Investment Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 2,995 shares of MDT stock, worth $244,212. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,995
Previous 4,732 36.71%
Holding current value
$244,212
Previous $372,000 27.69%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$76.84 - $91.03 $133,471 - $158,119
-1,737 Reduced 36.71%
2,995 $269,000
Q2 2024

Jul 30, 2024

SELL
$78.71 - $87.02 $518,384 - $573,113
-6,586 Reduced 58.19%
4,732 $372,000
Q1 2024

May 16, 2024

BUY
$82.84 - $88.09 $253,159 - $269,203
3,056 Added 36.99%
11,318 $986,000
Q4 2023

Feb 13, 2024

BUY
$69.43 - $83.43 $573,630 - $689,298
8,262 New
8,262 $680,000
Q2 2023

Aug 15, 2023

BUY
$79.47 - $91.38 $225,138 - $258,879
2,833 Added 74.12%
6,655 $586,000
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $79,405 - $90,645
1,035 Added 37.14%
3,822 $308,000
Q4 2022

Feb 10, 2023

SELL
$76.18 - $87.74 $55,763 - $64,225
-732 Reduced 20.8%
2,787 $216,000
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $284,159 - $335,395
3,519 New
3,519 $284,000
Q1 2020

May 06, 2020

SELL
$72.92 - $121.3 $173,549 - $288,694
-2,380 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$104.49 - $114.54 $31,451 - $34,476
301 Added 14.48%
2,380 $270,000
Q3 2019

Oct 15, 2019

BUY
$98.02 - $111.18 $203,783 - $231,143
2,079 New
2,079 $226,000
Q2 2019

Aug 13, 2019

SELL
$84.15 - $99.38 $287,793 - $339,879
-3,420 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $281,979 - $320,761
3,420 New
3,420 $311,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.